nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Antimicrobial resistance in Streptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrhalis and group A β-haemolytic streptococci in 2002–2003
|
Beekmann, Susan E. |
|
2005 |
25 |
2 |
p. 148-156 9 p. |
artikel |
2 |
Antimicrobial susceptibility of uncommonly isolated non-enteric Gram-negative bacilli
|
Sader, Helio S. |
|
2005 |
25 |
2 |
p. 95-109 15 p. |
artikel |
3 |
Antiproliferative synergism of azasterols and antifolates against Toxoplasma gondii
|
Dantas-Leite, Lucas |
|
2005 |
25 |
2 |
p. 130-135 6 p. |
artikel |
4 |
Clarithromycin co-administered with amikacin attenuates systemic inflammation in experimental sepsis with Escherichia coli
|
Giamarellos-Bourboulis, Evangelos J. |
|
2005 |
25 |
2 |
p. 168-172 5 p. |
artikel |
5 |
Efficacy of a new pharmacokinetically enhanced formulation of amoxicillin/clavulanate (2000/125mg) in adults with community-acquired pneumonia caused by Streptococcus pneumoniae, including penicillin-resistant strains
|
File, Thomas M. |
|
2005 |
25 |
2 |
p. 110-119 10 p. |
artikel |
6 |
Evolution of CTX-M-type β-lactamases in isolates of Escherichia coli infecting hospital and community patients
|
Brigante, Gioconda |
|
2005 |
25 |
2 |
p. 157-162 6 p. |
artikel |
7 |
Heterogeneous vancomycin-resistant Staphylococcus aureus (hetero-VISA) in Singapore
|
Sng, Li-Hwei |
|
2005 |
25 |
2 |
p. 177-179 3 p. |
artikel |
8 |
IFC - Aims/Scope/ Editorial Board
|
|
|
2005 |
25 |
2 |
p. CO2- 1 p. |
artikel |
9 |
Influence of various criteria for elimination of duplicates when calculating the prevalence and antibiotic susceptibility of microorganisms associated with urinary infections
|
Cebrián, L. |
|
2005 |
25 |
2 |
p. 173-176 4 p. |
artikel |
10 |
In vitro activity of C20-diterpenoid alkaloid derivatives in promastigotes and intracellular amastigotes of Leishmania infantum
|
González, Patricia |
|
2005 |
25 |
2 |
p. 136-141 6 p. |
artikel |
11 |
In vitro activity of meropenem in combination with ciprofloxacin against clinical isolates of Pseudomonas aeruginosa
|
Solak, Semiha |
|
2005 |
25 |
2 |
p. 181-182 2 p. |
artikel |
12 |
In vitro activity of new quinoxalin 1,4-dioxide derivatives against strains of Mycobacterium tuberculosis and other mycobacteria
|
Zanetti, S. |
|
2005 |
25 |
2 |
p. 179-181 3 p. |
artikel |
13 |
In vivo activity of gemifloxacin, moxifloxacin and levofloxacin against pneumococci with gyrA and parC point mutations in a sepsis mouse model measured with the all or nothing mortality end-point
|
Alkorta, M. |
|
2005 |
25 |
2 |
p. 163-167 5 p. |
artikel |
14 |
Molecular mechanisms of high level tetracycline-resistance in group A streptococcal isolates, T serotypes 4 and 11
|
Matsumoto, Masakado |
|
2005 |
25 |
2 |
p. 142-147 6 p. |
artikel |
15 |
Pharmacokinetic-pharmacodynamic modelling of antibacterial activity of cefpodoxime and cefixime in in vitro kinetic models
|
Liu, Ping |
|
2005 |
25 |
2 |
p. 120-129 10 p. |
artikel |
16 |
Prevalence of antibiotic use for acute respiratory infection in a primary care clinic in post-war Kabul province, Afghanistan
|
Morikawa, Masahiro J. |
|
2005 |
25 |
2 |
p. 182-183 2 p. |
artikel |
17 |
Use of Etest to assess synergy of antibiotic combinations against clinical isolates of Pseudomonas spp.
|
Fodor, E. |
|
2005 |
25 |
2 |
p. 183-184 2 p. |
artikel |